Home - Hong Kong Biotechnology Horizons
English 英文


Message from the President

As Hong Kong is hosting a world congress to commemorate its 20th Anniversary since its return to China, we are honoured and privileged to extend our warmest invitation to everyone in the world to join us at Hong Kong Biotech Horizon 2017 - “Global Congress on Biotechnology: Diagnostics and Therapeutics”, to be held during 22-25th November 2017 (Wed – Sat) at the iconic setting of Hong Kong Science Park (HKSP).

To facilitate East-meet-West exchange of expertise, views and ideas, the Congress will be conducted in English and Mandarin with Simultaneous Translation in both languages. All speakers can feel free to communicate in their native language for the most effective, personal and insightful meeting.

This Congress is part of Hong Kong Biotech Horizons (HKBH), the flagship event series run by Hong Kong Biotechnology Organization (HKBIO) whose objective is to bring together communities of scientific researchers, technology developers and entrepreneurs towards progress in translational science. The event series typically comprise of conference symposia and public talks engaging the public community and raising awareness of the importance of science in society.

This Congress will gather medical professionals, scientists, technologists as well as global leaders coming from China and worldwide who will share their insights on a broad and exciting programme comprising the latest developments in biotechnology. In addition, this Global Congress offers a great opportunity to meet and mingle with an enthusiastic crowd of participants who are keen to obtain first-hand information on how to leverage the golden opportunity of China’s economic growth, the Guangdong-Hong Kong-Macao Greater Bay AreaThe ‘Greater Bay Area’ refers to the Chinese government's scheme to link the cities of Hong Kong, Macau, Guangzhou, Shenzhen, Zhuhai, Foshan, Zhongshan, Dongguan, Huizhou, Jiangmen and Zhaoqing into an integrated economic and business hub., and the Belt and Road InitiativesA plan based around two core arteries: the Silk Road Economic Belt and the 21st Century Maritime Silk Road. “Belt and Road” is exactly what it says: the Belt is a land-based route leading from China to Europe via Central Asia, where the official outlines of the route stretch from Xi’an to Rotterdam in Holland; while the Road is its sea-based equivalent, passing through Southeast Asia, Africa and the Middle East on its way to Venice in Italy.

Covering more than 60 countries across Asia, Europe and Africa, accounting for 30% of global GDP and more than 30% of the world’s merchandise trade, the B&R Initiative seeks to promote market integration and forge new ties among different economies, with the objective of driving deeper regional development by promoting cooperation in a variety of areas, expanding business opportunities and encouraging people-to-people exchanges among different regions.

Hong Kong effectively leverages its prime position as “super-connector” between Mainland China and the rest of the world during China’s transformation under the B&R initiatives.


Hong Kong’s global-connectedness makes it especially vulnerable to infectious disease outbreaks and it is facing an epidemic challenge greater than the Spanish Flu almost a century ago. You can help us assess the current status of disease development and control by taking 5-10minutes to complete the survey on respiratory infectious diseases here which would entitle you to US$200 discount to attend the Congress.

Please take advantage of the early bird rate and register now. The first 200 registrants will receive a complimentary souvenir from HKBIO: a limited edition of Bauhinia DNA necklace (valued at US$200) created by renowned designer Elaine YoungNew York-based designer and founder of the LAByrinth Project, a fashion brand inspired by science. Elaine’s work has been featured in the Mori Arts Museum Shop in Tokyo, the MoMA Design Store [NYC and Tokyo] and at the Museum of Contemporary Art in Chicago.Elaine Young . A unique and perfect Christmas gift for your beloved!

For our American friends, we understand that the occasion overlaps with Thanksgiving holiday in the United States and many could not travel to Hong Kong during this important period with family and friends, however we also believe biotechnology is a very important topic for our mankind and this occasion should not be missed. If you could attend this Congress, we guarantee that you would have the best and most memorable Thanksgiving from Hong Kong! However, if you cannot make it, you can also sign up to our Webcast for exclusive access to any keynote lectures, workshops and panel discussions at the end of your fingertips, anywhere in the world.

We hope that you will share our enthusiasm for Hong Kong’s first Global Congress on Biotechnology and join us at this happy congruence of symposium and celebration!

All interested participants should proceed with registration and payment at the earliest. For further details or to register, please visit http://www.hkbio.org.hk/hkbh2017/index.php/en/ or email us at This email address is being protected from spambots. You need JavaScript enabled to view it..

We look forward to seeing you at this important conference in Hong Kong.

Albert Cheung-Hoi YU, Ph. D., J.P.

Congress President
Neuroscience Research Institute of Peking University  Vice Director / Professor
Hong Kong Biotechnology Organization  Chairman
Hong Kong Council for Testing and Certification  Chairman
HK20  Chairman


Who should attend?

The HKBH2017 will gather a complete list of stakeholders in the Hong Kong biotechnology ecosystems consisting of leading experts, researchers, regulators, device developers, entrepreneurs, preclinical scientists, innovators, solution providers as well as representatives from various organizations and companies including but not limited to pharmaceutical companies, venture capital, laboratories, industrial associations, financial institutions, and trade/logistics companies. In particular, we will introduce Chinese biotech companies and individuals.


Why should you attend?

  • Capture Asia’s biotech market opportunities through Hong Kong
  • Find partners, sustain project and find funding from the world
  • Discuss with biotech professionals current and future issues in Diagnostics and Therapeutics
  • Learn about projects related to Diagnostics and Therapeutics fields in the world
  • Network with top executives, investors, experts and renowned leaders from the world
  • Sessions exploring the latest on biotechnology’s hot topics
  • Explore R&D, products and services


Our Speakers

The Organizer

Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business, the vision of the Hong Kong Biotechnology Organization is to establish and facilitate a worldwide platform for the Hong Kong biotech industry, promoting awareness, encouraging and enabling international collaboration and providing informed opinion and technical advice to government bodies, healthcare institutions and the general public.

Established and registered under Cap. 151 of the Societies Ordinance (CP/LIC/SO/19/57868), HK20 are dedicated to influencing the Hong Kong society with positive attitude to welcoming the 20th Anniversary of the establishment of HKSAR. We aim to promote participation, to transmit positive energy and to structure a harmonious society through celebrations and events. Our ultimate goal is to constitute the biggest and the most dazzling birthday party by getting every single individual in Hong Kong involved.


Contact Us

Telephone:  +852 2799 7688
Fax:  +852 2111 9762
Email:  info@hkbio.org.hk
Mail:  Units 601-605, 6/F, Biotech Centre One,
9 Science Park West Avenue,
Hong Kong Science Park, Shatin,
New Territories, Hong Kong